株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

前臨床画像 (In-VIVO) の世界市場予測 2021年:光学画像、PET、SPECT、CT、MRI、超音波、光音響画像、磁性粒子画像 (MPI)

Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, Ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 256349
出版日 ページ情報 英文 165 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
前臨床画像 (In-VIVO) の世界市場予測 2021年:光学画像、PET、SPECT、CT、MRI、超音波、光音響画像、磁性粒子画像 (MPI) Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, Ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent - Global Forecast to 2021
出版日: 2016年08月31日 ページ情報: 英文 165 Pages
概要

世界の前臨床画像市場は、予測期間中に6.2%のCAGR (複合年間成長率) で拡大し、2021年には9億1040万米ドルの規模に達する、と予測されています。分子画像技術の進歩や、小動物画像技術の需要拡大、官民合同での資金援助などが、同市場の成長を促進しています。さらに、中国・インド・韓国・台湾などの新興国市場では新たな成長機会が出現しつつあります。他方、厳格な規制や巨額の資本・運用費用などが、市場成長の妨げとなっています。

当レポートでは、世界の前臨床画像市場について調査し、モダリティ、試薬、および地域別の市場分析と予測を提供しており、競合環境の分析、および主要企業のプロファイルなどをまとめ、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 前臨床画像 (In-VIVO) の世界市場:概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
      • 分子画像分野での技術進歩
      • 低侵襲的・小動物イメージング技術の市場需要の拡大
      • 官民連携による、前臨床試験向け支援策・資金提供件数の増加
    • 抑制要因
      • 前臨床試験に対する厳格な規制
      • 前臨床画像モダリティに関する巨額の設置・運用コスト
    • 市場機会
      • 新興国市場での新たな成長機会
    • 課題
      • スタンドアロン式 (単独型) 画像装置に関する技術面・処置面での限界

第6章 前臨床画像 (In-VIVO) の世界市場:産業考察

  • イントロダクション
  • バリューチェーン分析
  • サプライチェーン分析
    • 主な利害関係者 (ステークホルダー)
    • 主な影響要因
  • 主な産業動向
    • 現在進行中の、ハイブリッド/マルチモーダル前臨床画像システム
  • ポーターのファイブフォース分析

第7章 前臨床画像 (In-VIVO) の世界市場:モダリティ別

  • イントロダクション
  • 光学画像システム
    • 生物発光・蛍光発光画像システム
    • (光学+X線)/(光学+CT) 画像システム
    • スタンドアロン型蛍光発光画像システム
  • 核イメージングシステム
    • マイクロPETシステム
      • スタンドアロン型PETシステム
      • PET/CTシステム
      • PET/MRIシステム
    • マイクロSPECTシステム
      • スタンドアロン型SPECTシステム
      • SPECT/CTシステム
      • SPECT/MRIシステム
    • トライモダリティ (SPECT/PET/CT) システム
  • マイクロMRIシステム
  • マイクロ超音波システム
  • マイクロCTシステム
  • 光音響画像システム
  • 磁性粒子画像 (MPI) システム

第8章 前臨床画像 (In-VIVO) の世界市場:試薬別

  • イントロダクション
  • 前臨床光学画像試薬
    • 生体発光画像試薬
      • ルシフェリン
      • プロルシフェリン (Proluciferin)
      • セレンテラジン
      • その他
    • 蛍光発光画像試薬
      • 緑色蛍光タンパク質
      • 赤色蛍光タンパク質
      • 赤外色素
      • その他
  • 前臨床核イメージング試薬
    • 前臨床PETトレーサー
      • フッ素18系前臨床PETトレーサー
      • 炭素11系前臨床PETトレーサー
      • 銅64系前臨床PETトレーサー
      • その他
    • 前臨床SPECTプローブ
      • テクネチウム99m系前臨床SPECTプローブ
      • ヨウ素131系前臨床SPECTプローブ
      • ガリウム67系前臨床SPECTプローブ
      • タリウム201系前臨床SPECTプローブ
      • その他
  • 前臨床MRI造影剤
    • ガドリニウム系前臨床造影剤
    • 鉄ベース前臨床造影剤
    • マンガン系前臨床造影剤
  • 前臨床超音波造影剤
  • 前臨床CT造影剤
    • ヨウ素ベース前臨床CT造影剤
    • バリウム系前臨床CT造影剤
    • 金ナノ粒子
    • ガストログラフィン系前臨床CT造影剤

第9章 前臨床画像 (In-VIVO) の世界市場:試薬別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 他の国々 (RoW)

第10章 競合環境

  • 概要
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 新製品の上市
    • 協定・事業提携・事業協力
    • 世界各地への進出
    • 企業買収

第11章 企業プロファイル

  • イントロダクション
    • 地域間の比較分析
  • PERKINELMER, INC.
  • BRUKER CORPORATION
  • 富士フイルムホールディングス
  • MEDISO LTD.
  • MILABS B.V.
  • MR SOLUTIONS LTD.
  • ASPECT IMAGING LTD.
  • LI-COR BIOSCIENCES, INC.
  • TRIFOIL IMAGING, INC.
  • MILTENYI BIOTEC GMBH

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3117

The global preclinical imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is expected to be valued at USD 910.4 million by 2021. Although the mature markets (North America and Europe) held large share of preclinical imaging market in 2015; Asia-Pacific region is poised to be the fastest growing region during next five years. Factors such as continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries are propelling the growth of the preclinical imaging market in Asia-Pacific region.

Market growth in the global preclinical imaging market is mainly driven by factors such technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches. In addition, emerging markets (such as China and India) are offering new growth opportunities for preclinical imaging market players.

Geographically, North America is estimated to command the largest share of the global preclinical imaging market in 2016, followed by Europe. The large market share of the North American region can be attributed to the robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems. However, continued outsourcing of in-house preclinical studies to emerging countries by U.S.-based pharmaceutical and biotechnology companies and reduced R&D expenditure by the Canadian government to support research studies are negatively affecting the growth of the preclinical imaging market in this region.

The preclinical imaging market is fairly competitive, with a large number of global and local manufacturers of preclinical imaging solutions. PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), and FUJIFILM Holding Corporation (Japan) were the top three players in the preclinical imaging market in 2015. These companies together accounted for a share of 63.2% of the global preclinical imaging market in 2015. New product launches and product enhancements; geographic expansions; and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the preclinical imaging market.

Report Objectives:

This report studies preclinical imaging market based on modality and reagents; utilized for the assessment of anatomical, physiological, and functional parameters at molecular and cellular levels in live animal models. These imaging systems and reagents are applied to visualize living animals during preclinical research studies in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications.

The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the preclinical imaging market report analyzes the micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market.

Detailed Segmentation:

Preclinical Imaging Market, by Modality:

  • Optical Imaging Systems
  • Bioluminescence/Fluorescence Imaging Systems
  • Standalone Fluorescence Imaging Systems
  • Optical + X-Ray/Optical + CT
  • Preclinical Nuclear Imaging Systems
  • Micro-PET Systems
  • Micro-SPECT Systems
  • Trimodality (SPECT/PET/CT) Systems
  • Micro-MRI Systems
  • Micro-Ultrasound Systems
  • Micro-CT Systems
  • Preclinical Photoacoustic Imaging Systems
  • Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical Imaging Market, by Reagents:

  • Preclinical Optical Imaging Reagents
  • Bioluminescent Imaging Reagents
  • Fluorescent Imaging Reagents
  • Preclinical Nuclear Imaging Reagents
  • Preclinical PET Tracers
  • Preclinical SPECT Probes
  • Preclinical MRI Contrast Agents
  • Gadolinium-based Preclinical MRI Contrast Agents
  • Iron-based Preclinical MRI Contrast Agents
  • Manganese-based Preclinical MRI Contrast Agents
  • Preclinical Ultrasound Contrast Agents
  • Preclinical CT Contrast Agents
  • Iodine-based Preclinical CT Contrast Agents
  • Barium-based Preclinical CT Contrast Agents
  • Gold Nanoparticles
  • Gastrografin-based Preclinical CT Contrast Agents

Preclinical Imaging Market, by Region:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Key Target Audience:

  • Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
  • Pharmaceutical and Biotechnology Companies
  • Preclinical Imaging Reagent Manufacturers and Suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Independent Research Laboratories
  • Government and Independent Regulatory Authorities
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
      • 1.3.1.1. Preclinical imaging market segmentation
      • 1.3.1.2. Preclinical imaging systems market segmentation
      • 1.3.1.3. Preclinical imaging reagents market segmentation
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
      • 2.2.1.1. Bottom-up approach
      • 2.2.1.2. Top-down approach
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL PRECLINICAL IMAGING MARKET
  • 4.2. PRECLINICAL IMAGING PRODUCTS MARKET SHARE, BY REGION (2016)
  • 4.3. GLOBAL PRECLINICAL IMAGING SYSTEMS MARKET, BY MODALITY (2016-2021)
  • 4.4. GLOBAL PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE (2016-2021)
  • 4.5. PRECLINICAL IMAGING MARKET, BY REGION (2016 VS. 2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Technological advancements in the field of molecular imaging
      • 5.2.1.2. Increasing market demand for noninvasive small-animal imaging techniques
      • 5.2.1.3. Growing number of public-private initiatives and funding to support preclinical researches
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. Strict regulations governing preclinical research
      • 5.2.2.2. Significant installation and operational costs associated with preclinical imaging modalities
    • 5.2.3. KEY MARKET OPPORTUNITY
      • 5.2.3.1. Emerging markets to offer new growth opportunities
    • 5.2.4. KEY MARKET CHALLENGE
      • 5.2.4.1. Technological and procedural limitations associated with standalone preclinical imaging systems

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. SUPPLY CHAIN ANALYSIS
    • 6.3.1. KEY STAKEHOLDERS
    • 6.3.2. KEY INFLUENCERS
  • 6.4. KEY INDUSTRY TREND
    • 6.4.1. ONGOING DEVELOPMENT OF HYBRID AND MULTI-MODALITY PRECLINICAL IMAGING SYSTEMS
  • 6.5. PORTER'S FIVE FORCES ANALYSIS
    • 6.5.1. THREAT OF NEW ENTRANTS
    • 6.5.2. THREAT OF SUBSTITUTES
    • 6.5.3. BARGAINING POWER OF SUPPLIERS
    • 6.5.4. BARGAINING POWER OF BUYERS
    • 6.5.5. INTENSITY OF COMPETITIVE RIVALRY

7. GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY

  • 7.1. INTRODUCTION
  • 7.2. OPTICAL IMAGING SYSTEMS
    • 7.2.1. BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS
    • 7.2.2. (OPTICAL + X-RAY)/(OPTICAL + CT) IMAGING SYSTEMS
    • 7.2.3. STANDALONE FLUORESCENCE IMAGING SYSTEMS
  • 7.3. NUCLEAR IMAGING SYSTEMS
    • 7.3.1. MICRO-PET SYSTEMS
      • 7.3.1.1. Standalone PET Systems
      • 7.3.1.2. PET/CT Systems
      • 7.3.1.3. PET/MRI Systems
    • 7.3.2. MICRO-SPECT SYSTEMS
      • 7.3.2.1. Standalone SPECT Systems
      • 7.3.2.2. SPECT/CT Systems
      • 7.3.2.3. SPECT/MRI Systems
    • 7.3.3. TRIMODALITY (SPECT/PET/CT) SYSTEMS
  • 7.4. MICRO-MRI SYSTEMS
  • 7.5. MICRO-ULTRASOUND SYSTEMS
  • 7.6. MICRO-CT SYSTEMS
  • 7.7. PHOTOACOUSTIC IMAGING SYSTEMS
  • 7.8. MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS

8. GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENT

  • 8.1. INTRODUCTION
  • 8.2. PRECLINICAL OPTICAL IMAGING REAGENTS
    • 8.2.1. BIOLUMINESCENT IMAGING REAGENTS
      • 8.2.1.1. Luciferins
      • 8.2.1.2. Proluciferins
      • 8.2.1.3. Coelenterazine
      • 8.2.1.4. Other Bioluminescent Imaging Reagents
    • 8.2.2. FLUORESCENT IMAGING REAGENTS
      • 8.2.2.1. Green Fluorescent Proteins
      • 8.2.2.2. Red Fluorescent Proteins
      • 8.2.2.3. Infrared Dyes
      • 8.2.2.4. Other fluorescent imaging reagents
  • 8.3. PRECLINICAL NUCLEAR IMAGING REAGENTS
    • 8.3.1. PRECLINICAL PET TRACERS
      • 8.3.1.1. Fluorine-18-based Preclinical PET Tracers
      • 8.3.1.2. Carbon-11-based Preclinical PET Tracers
      • 8.3.1.3. Copper-64-based Preclinical PET Tracers
      • 8.3.1.4. Other PET tracers
    • 8.3.2. PRECLINICAL SPECT PROBES
      • 8.3.2.1. Technetium-99m-based Preclinical SPECT Probes
      • 8.3.2.2. Iodine-131-based Preclinical SPECT Probes
      • 8.3.2.3. Gallium-67-based Preclinical SPECT Probes
      • 8.3.2.4. Thallium-201-based Preclinical SPECT Probes
      • 8.3.2.5. Other SPECT probes
  • 8.4. PRECLINICAL MRI CONTRAST AGENTS
    • 8.4.1. GADOLINIUM-BASED PRECLINICAL CONTRAST AGENTS
    • 8.4.2. IRON-BASED PRECLINICAL CONTRAST AGENTS
    • 8.4.3. MANGANESE-BASED PRECLINICAL CONTRAST AGENTS
  • 8.5. PRECLINICAL ULTRASOUND CONTRAST AGENTS
  • 8.6. PRECLINICAL CT CONTRAST AGENTS
    • 8.6.1. IODINE-BASED PRECLINICAL CT CONTRAST AGENTS
    • 8.6.2. BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS
    • 8.6.3. GOLD NANOPARTICLES
    • 8.6.4. GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS

9. PRECLINICAL IMAGING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
  • 9.3. EUROPE
  • 9.4. ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. NEW PRODUCT LAUNCHES
    • 10.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.3.3. GEOGRAPHICAL EXPANSIONS
    • 10.3.4. ACQUISITIONS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. INTRODUCTION
    • 11.1.1. GEOGRAPHIC BENCHMARKING
  • 11.2. PERKINELMER, INC.
  • 11.3. BRUKER CORPORATION
  • 11.4. FUJIFILM HOLDINGS CORPORATION
  • 11.5. MEDISO LTD.
  • 11.6. MILABS B.V.
  • 11.7. MR SOLUTIONS LTD.
  • 11.8. ASPECT IMAGING LTD.
  • 11.9. LI-COR BIOSCIENCES, INC.
  • 11.10. TRIFOIL IMAGING, INC.
  • 11.11. MILTENYI BIOTEC GMBH

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 2: GLOBAL OPTICAL IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: OPTICAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2014 (USD MILLION)
  • TABLE 5: (OPTICAL + X-RAY)/(OPTICAL + CT) IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2014 (USD MILLION)
  • TABLE 6: STANDALONE FLUORESCENCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2012-2014 (USD MILLION)
  • TABLE 7: GLOBAL NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 8: NUCLEAR IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL MICRO-PET SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: MICRO-PET SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: STANDALONE PET SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: PET/CT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: PET/MRI SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL MICRO-SPECT SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 15: MICRO-SPECT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: STANDALONE SPECT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: SPECT/CT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: SPECT/MRI SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: TRIMODALITY SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: MICRO-MRI SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: MICRO-ULTRASOUND SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: MICRO-CT SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: PHOTOACOUSTIC IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: MAGNETIC PARTICLE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: PRECLINICAL OPTICAL IMAGING REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: PRECLINICAL LUCIFERINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: PRECLINICAL PROLUCIFERINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: PRECLINICAL COELENTERAZINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: OTHER PRECLINICAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 35: PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: PRECLINICAL GREEN FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: PRECLINICAL RED FLUORESCENT PROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: PRECLINICAL INFRARED DYES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: OTHER PRECLINICAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 41: PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL PRECLINICAL PET TRACERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 43: PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: FLUORINE-18-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: CARBON-11-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: COPPER-64-BASED PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: OTHER PRECLINICAL PET TRACERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: GLOBAL PRECLINICAL SPECT PROBES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: TECHNETIUM-99M-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: IODINE-131-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: GALLIUM-67-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: THALLIUM-201-BASED PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: OTHER PRECLINICAL SPECT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: GLOBAL PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: PRECLINICAL MRI CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: GADOLINIUM-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: IRON-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: MANGANESE-BASED PRECLINICAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: PRECLINICAL ULTRASOUND CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 63: IODINE-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 64: BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: GOLD NANOPARTICLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 66: GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: GLOBAL PRECLINICAL IMAGING SYSTEMS AND REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 68: NORTH AMERICA: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: EUROPE: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 76: ASIA-PACIFIC: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: PRECLINICAL IMAGING SYSTEMS MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 79: ROW: PRECLINICAL IMAGING REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: TOP NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 81: TOP AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 82: TOP GEOGRAPHICAL EXPANSIONS, 2013-2016
  • TABLE 83: TOP ACQUISITIONS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: PRECLINICAL IMAGING SYSTEMS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: PRECLINICAL IMAGING SYSTEMS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: PRECLINICAL IMAGING REAGENTS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: PRECLINICAL IMAGING MARKET: DATA TRIANGULATION
  • FIGURE 7: GLOBAL PRECLINICAL IMAGING SYSTEMS MARKET, BY MODALITY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL PRECLINICAL IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL PRECLINICAL IMAGING MARKET, BY REGION, 2016
  • FIGURE 10: TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR IMAGING AND INCREASING DEMAND FOR NONINVASIVE TECHNIQUES-KEY MARKET DRIVERS
  • FIGURE 11: NORTH AMERICA IS EXPECTED TO DOMINATE THE PRECLINICAL IMAGING MARKET IN 2016
  • FIGURE 12: OPTICAL IMAGING, NUCLEAR IMAGING, AND MICRO-MRI SYSTEMS TO DOMINATE THE PRECLINICAL IMAGING SYSTEMS MARKET TILL 2021
  • FIGURE 13: OPTICAL IMAGING, NUCLEAR IMAGING REAGENTS AND MRI CONTRAST AGENTS TO DOMINATE THE REAGENTS MARKET TILL 2021
  • FIGURE 14: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PRECLINICAL IMAGING MARKET IN 2016
  • FIGURE 15: TECHNOLOGICAL ADVANCEMENTS & EMERGING APPLICATION SEGMENTS TO DRIVE THE GROWTH OF THE PRECLINICAL IMAGING MARKET TILL 2021
  • FIGURE 16: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000-2013
  • FIGURE 17: MAJORITY OF PRODUCT VALUE OF PRECLINICAL IMAGING SYSTEMS IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
  • FIGURE 18: MARKET PLAYERS PREFER BOTH DIRECT & INDIRECT DISTRIBUTION STRATEGIES
  • FIGURE 19: PORTER'S FIVE FORCES ANALYSIS: PRECLINICAL IMAGING MARKET (2015)
  • FIGURE 20: OPTICAL IMAGING SYSTEMS TO DOMINATE PRECLINICAL IMAGING SYSTEMS MARKET TILL 2021
  • FIGURE 21: OPTICAL IMAGING SYSTEMS MARKET TO BE DOMINATED BY BIOLUMINESCENCE AND FLUORESCENCE IMAGING SYSTEMS IN 2016
  • FIGURE 22: MICRO-PET SYSTEMS TO DOMINATE THE NUCLEAR IMAGING SYSTEMS MARKET TILL 2021
  • FIGURE 23: MAGNETIC PARTICLE IMAGING VS. OTHER PRECLINICAL IMAGING MODALITIES - ADVANTAGES AND KEY APPLICATION AREAS
  • FIGURE 24: OPTICAL IMAGING REAGENTS TO DOMINATE THE PRECLINICAL IMAGING REAGENTS MARKET TILL 2021
  • FIGURE 25: PRECLINICAL OPTICAL IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 26: PRECLINICAL NUCLEAR IMAGING REAGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 27: PRECLINICAL MRI CONTRAST AGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 28: PRECLINICAL CT CONTRAST AGENTS MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 29: ASIA-PACIFIC TO BE THE FASTEST-GROWING REGION IN GLOBAL PRECLINICAL IMAGING MARKET DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA: PRECLINICAL IMAGING MARKET SNAPSHOT (2016-2021)
  • FIGURE 31: EUROPE: PRECLINICAL IMAGING MARKET SNAPSHOT (2016-2021)
  • FIGURE 32: ASIA-PACIFIC: PRECLINICAL IMAGING MARKET SNAPSHOT (2016-2021)
  • FIGURE 33: ROW: PRECLINICAL IMAGING MARKET SNAPSHOT (2016-2021)
  • FIGURE 34: NEW PRODUCT LAUNCHES: KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF MARKET PLAYERS (2013-2016)
  • FIGURE 35: GLOBAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER (2015)
  • FIGURE 36: INCREASING NUMBER OF NEW PRODUCTS LAUNCHED IS STIMULATING THE MARKET GROWTH
  • FIGURE 37: GEOGRAPHIC REVENUE MIX OF THE TOP 3 MARKET PLAYERS (2015)
  • FIGURE 38: PERKINELMER, INC.: COMPANY SNAPSHOT
  • FIGURE 39: BRUKER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40: FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
Back to Top